341 related articles for article (PubMed ID: 28707358)
21. Oligodendrocyte-specific activation of PERK signaling protects mice against experimental autoimmune encephalomyelitis.
Lin W; Lin Y; Li J; Fenstermaker AG; Way SW; Clayton B; Jamison S; Harding HP; Ron D; Popko B
J Neurosci; 2013 Apr; 33(14):5980-91. PubMed ID: 23554479
[TBL] [Abstract][Full Text] [Related]
22. Functional interleukin-17 receptor A is expressed in central nervous system glia and upregulated in experimental autoimmune encephalomyelitis.
Das Sarma J; Ciric B; Marek R; Sadhukhan S; Caruso ML; Shafagh J; Fitzgerald DC; Shindler KS; Rostami A
J Neuroinflammation; 2009 Apr; 6():14. PubMed ID: 19400960
[TBL] [Abstract][Full Text] [Related]
23. RON-regulated innate immunity is protective in an animal model of multiple sclerosis.
Tsutsui S; Noorbakhsh F; Sullivan A; Henderson AJ; Warren K; Toney-Earley K; Waltz SE; Power C
Ann Neurol; 2005 Jun; 57(6):883-95. PubMed ID: 15929040
[TBL] [Abstract][Full Text] [Related]
24. Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis.
Gonçalves ED; Souza PS; Lieberknecht V; Fidelis GS; Barbosa RI; Silveira PC; de Pinho RA; Dutra RC
Autoimmunity; 2016; 49(2):132-42. PubMed ID: 26703077
[TBL] [Abstract][Full Text] [Related]
25. Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System.
Thomé R; de Carvalho AC; Alves da Costa T; Ishikawa LL; Fraga-Silva TF; Sartori A; de Oliveira AL; Verinaud L
CNS Neurosci Ther; 2016 Aug; 22(8):707-14. PubMed ID: 27165523
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis.
Kanwar JR; Kanwar RK; Krissansen GW
Brain; 2004 Jun; 127(Pt 6):1313-31. PubMed ID: 15130951
[TBL] [Abstract][Full Text] [Related]
27. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
[TBL] [Abstract][Full Text] [Related]
28. Expression of IL-1β in rhesus EAE and MS lesions is mainly induced in the CNS itself.
Burm SM; Peferoen LA; Zuiderwijk-Sick EA; Haanstra KG; 't Hart BA; van der Valk P; Amor S; Bauer J; Bajramovic JJ
J Neuroinflammation; 2016 Jun; 13(1):138. PubMed ID: 27266875
[TBL] [Abstract][Full Text] [Related]
29. Oligodendrocyte-specific FADD deletion protects mice from autoimmune-mediated demyelination.
Mc Guire C; Volckaert T; Wolke U; Sze M; de Rycke R; Waisman A; Prinz M; Beyaert R; Pasparakis M; van Loo G
J Immunol; 2010 Dec; 185(12):7646-53. PubMed ID: 21068410
[TBL] [Abstract][Full Text] [Related]
30. Diminished cytokine and chemokine expression in the central nervous system of GMF-deficient mice with experimental autoimmune encephalomyelitis.
Zaheer A; Sahu SK; Wu Y; Zaheer A; Haas J; Lee K; Yang B
Brain Res; 2007 May; 1144():239-47. PubMed ID: 17316572
[TBL] [Abstract][Full Text] [Related]
31. Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.
Junqueira SC; Dos Santos Coelho I; Lieberknecht V; Cunha MP; Calixto JB; Rodrigues ALS; Santos ARS; Dutra RC
Mol Neurobiol; 2017 Jul; 54(5):3271-3285. PubMed ID: 27130268
[TBL] [Abstract][Full Text] [Related]
32. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway.
Linker RA; Lee DH; Ryan S; van Dam AM; Conrad R; Bista P; Zeng W; Hronowsky X; Buko A; Chollate S; Ellrichmann G; Brück W; Dawson K; Goelz S; Wiese S; Scannevin RH; Lukashev M; Gold R
Brain; 2011 Mar; 134(Pt 3):678-92. PubMed ID: 21354971
[TBL] [Abstract][Full Text] [Related]
33. Capparis ovata treatment suppresses inflammatory cytokine expression and ameliorates experimental allergic encephalomyelitis model of multiple sclerosis in C57BL/6 mice.
Ozgun-Acar O; Celik-Turgut G; Gazioglu I; Kolak U; Ozbal S; Ergur BU; Arslan S; Sen A; Topcu G
J Neuroimmunol; 2016 Sep; 298():106-16. PubMed ID: 27609283
[TBL] [Abstract][Full Text] [Related]
34. Genetic inactivation of the adenosine A(2A) receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitis.
Yao SQ; Li ZZ; Huang QY; Li F; Wang ZW; Augusto E; He JC; Wang XT; Chen JF; Zheng RY
J Neurochem; 2012 Oct; 123(1):100-12. PubMed ID: 22639925
[TBL] [Abstract][Full Text] [Related]
35. Differential expression of protease M/neurosin in oligodendrocytes and their progenitors in an animal model of multiple sclerosis.
Terayama R; Bando Y; Jiang YP; Mitrovic B; Yoshida S
Neurosci Lett; 2005 Jul 1-8; 382(1-2):82-7. PubMed ID: 15911126
[TBL] [Abstract][Full Text] [Related]
36. Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity.
Eitan E; Hutchison ER; Greig NH; Tweedie D; Celik H; Ghosh S; Fishbein KW; Spencer RG; Sasaki CY; Ghosh P; Das S; Chigurapati S; Raymick J; Sarkar S; Chigurupati S; Seal S; Mattson MP
Exp Neurol; 2015 Nov; 273():151-60. PubMed ID: 26277686
[TBL] [Abstract][Full Text] [Related]
37. Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
Eltayeb S; Berg AL; Lassmann H; Wallström E; Nilsson M; Olsson T; Ericsson-Dahlstrand A; Sunnemark D
J Neuroinflammation; 2007 May; 4():14. PubMed ID: 17484785
[TBL] [Abstract][Full Text] [Related]
38. Abnormal morphology of myelin and axon pathology in murine models of multiple sclerosis.
Bando Y; Nomura T; Bochimoto H; Murakami K; Tanaka T; Watanabe T; Yoshida S
Neurochem Int; 2015 Feb; 81():16-27. PubMed ID: 25595039
[TBL] [Abstract][Full Text] [Related]
39. Matrine promotes oligodendrocyte development in CNS autoimmunity through the PI3K/Akt signaling pathway.
Liu SQ; Zhang ML; Zhang HJ; Liu FZ; Chu RJ; Zhang GX; Zhu L
Life Sci; 2017 Jul; 180():36-41. PubMed ID: 28499934
[TBL] [Abstract][Full Text] [Related]
40. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.
van Strien ME; de Vries HE; Chrobok NL; Bol JGJM; Breve JJP; van der Pol SMP; Kooij G; van Buul JD; Karpuj M; Steinman L; Wilhelmus MM; Sestito C; Drukarch B; Van Dam AM
Brain Behav Immun; 2015 Nov; 50():141-154. PubMed ID: 26133787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
